The Technical Analyst
Select Language :
Fulgent Genetics Inc [FLGT]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research

Fulgent Genetics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Fulgent Genetics Inc is listed at the  Exchange

0.05% $21.70

America/New_York / 28 mar 2024 @ 16:00


Fulgent Genetics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 646.33 mill
EPS: -5.63
P/E: -3.85
Earnings Date: May 02, 2024
SharesOutstanding: 29.78 mill
Avg Daily Volume: 0.212 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -3.85 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.21x
Company: PE -3.85 | industry: PE 18.71
DISCOUNTED CASH FLOW VALUE
$53.95
(148.63%) $32.25
Date: 2024-03-28
Expected Trading Range (DAY)

$ 20.70 - 22.66

( +/- 4.50%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-08 Hsieh Ming Buy 1 000 000 Forward sale contract (obligation to sell)
2024-03-08 Hsieh Ming Sell 1 000 000 Forward sale contract (obligation to sell)
2024-03-01 Xie Jian Sell 1 075 Common Stock
2024-03-01 Xie Jian Sell 404 Common Stock
2024-03-01 Kim Paul Sell 1 129 Common Stock
INSIDER POWER
2.47
Last 99 transactions
Buy: 2 068 563 | Sell: 1 956 842

Forecast: 16:00 - $21.70

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $21.70
Forecast 2: 16:00 - $21.70
Forecast 3: 16:00 - $21.70
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $21.70 (0.05% )
Volume 0.148 mill
Avg. Vol. 0.212 mill
% of Avg. Vol 69.76 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Fulgent Genetics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Fulgent Genetics Inc

RSI

Intraday RSI14 chart for Fulgent Genetics Inc

Last 10 Buy & Sell Signals For FLGT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:34sell$25.16N/AActive
Profile picture for
            Fulgent Genetics Inc

FLGT

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests, as well as antigen-based diagnostic tests for the detection of SARS-CoV-2. In addition, the company offers flow cytometry, a cell analysis technique providing diagnosis, prognosis, and monitoring of malignancies; fluorescence in-situ hybridization for detecting and locating a specific DNA sequence on a chromosome; immunohistochemistry, an imaging technique used to visualize antigens in cells; cytogenetics, which analyzes the chromosome set for numerical and structural abnormalities; and molecular testing that includes hematopoietic and solid tumor molecular assays. The company serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. Fulgent Genetics has strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Last 10 Buy Signals

Date Signal @
FISUSDMar 28 - 19:030.952
PROPCUSDMar 28 - 18:585.09
XCADUSDMar 28 - 18:571.490
INDEXUSDMar 28 - 18:565.95
FUMOUSDMar 28 - 18:5410 001
ALPHUSDMar 28 - 18:542.71
HNTUSDMar 28 - 18:47$6.19
WBTUSDMar 28 - 18:438.37
TRXUSDMar 28 - 18:39$0.120
XMRUSDMar 28 - 18:34$135.06

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.